Jakafi Xr 50881-0033
Generic: Ruxolitinib
Product NDC
50881-0033- Manufacturer
- Incyte Corporation
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2026
- Listing Expires
- December 31, 2027
- Application
- NDA217180
Need to source Jakafi Xr? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ruxolitinib | 33 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]
Packaging Options(1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-033-08)